V1RF2 inhibitors are a specialized class of chemical compounds designed to target and modulate the activity of the V1RF2 protein. The V1RF2 protein plays a significant role in various cellular processes due to its involvement in specific biochemical pathways and regulatory mechanisms. The structure of V1RF2 includes distinct functional domains that are critical for its interaction with other proteins and cellular components. V1RF2 inhibitors are engineered to bind to these crucial sites, thereby interfering with the protein's normal functions. The binding of these inhibitors can alter the protein's activity, affecting the downstream pathways it regulates.
The chemical class of V1RF2 inhibitors encompasses a range of compounds, each with unique structural characteristics. These inhibitors are designed through a detailed understanding of V1RF2's structure and function, aiming to achieve selective and effective modulation. The compounds may include a variety of chemical groups that interact with specific regions of the V1RF2 protein. By precisely targeting these regions, V1RF2 inhibitors can disrupt the protein's interactions and influence its regulatory roles within the cell. The development of these inhibitors involves intricate research into the protein's molecular interactions and structural biology to ensure that the inhibitors bind effectively and specifically to V1RF2, thereby impacting its function in a controlled manner.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Diosgenin | 512-04-9 | sc-205652 sc-205652B sc-205652A | 5 g 25 g 100 g | $47.00 $131.00 $517.00 | 4 | |
Diosgenin may inhibit V1R235 expression by interfering with transcription factors or modulating signaling pathways. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $158.00 | 6 | |
Celastrol has been shown to inhibit gene expression by interfering with transcription factors or signaling cascades. | ||||||
Wogonin, S. baicalensis | 632-85-9 | sc-203313 | 10 mg | $200.00 | 8 | |
Wogonin may inhibit V1R235 expression by modulating transcriptional regulators or signaling cascades. | ||||||
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $117.00 $344.00 | 3 | |
Betulinic acid can modulate gene expression through interactions with transcriptional regulators or signaling pathways. | ||||||
Tanshinone IIA | 568-72-9 | sc-200932 sc-200932A | 5 mg 25 mg | $88.00 $316.00 | 22 | |
Tanshinone IIA may inhibit V1R235 expression by affecting transcriptional machinery or modulating signaling pathways. | ||||||
Artemisinin | 63968-64-9 | sc-202960 sc-202960A | 100 mg 1 g | $45.00 $252.00 | 1 | |
Artemisinin can inhibit gene expression through interactions with transcription factors or signaling pathways. | ||||||
Guggulsterone | 95975-55-6 | sc-203990 sc-203990A | 10 mg 50 mg | $145.00 $615.00 | 1 | |
Guggulsterone has been shown to inhibit gene expression through interference with transcriptional machinery or signaling pathways. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $130.00 $583.00 $4172.00 $20506.00 | 20 | |
Withaferin A may inhibit V1R235 expression by interfering with transcriptional regulators or signaling cascades. | ||||||
Xanthohumol from hop (Humulus lupulus) | 6754-58-1 | sc-301982 | 5 mg | $361.00 | 1 | |
Xanthohumol can modulate gene expression through interactions with transcriptional regulators or signaling pathways. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane may inhibit V1R235 expression by affecting transcriptional machinery or modulating signaling pathways. | ||||||